Nanomedicine Market Report

Global and Region Nanomedicine Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：181
  • REPORT CODE：GMM976359
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Nanomedicine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Nanomedicinemarket, defines the market attractiveness level of Nanomedicine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Nanomedicine industry, describes the types of Nanomedicine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nanomedicine market and the development prospects and opportunities of Nanomedicine industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nanomedicine market in Chapter 13.

    By Player:

    • Nanosphere Inc

    • Pfizer Inc

    • Smith & Nephew PLC

    • Sigma-Tau Pharmaceuticals Inc

    • Mallinckrodt plc

    • Merck & Co Inc

    • GE Healthcare

    • Johnson & Johnson

    • Stryker Corp

    • Teva Pharmaceutical Industries Ltd

    • UCB (Union chimique belge) SA

    By Type:

    • Regenerative Medicine

    • In-vitro & In-vivo Diagnostics

    • Vaccines

    • Drug Delivery

    By End-User:

    • Clinical Cardiology

    • Urology

    • Genetics

    • Orthopedics

    • Ophthalmology

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Nanomedicine Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Nanomedicine Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Nanomedicine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Nanomedicine Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Nanomedicine Market Analysis and Outlook to 2022

    • 7.1 Global Nanomedicine Consumption (2017-2022)

    • 7.2 United States Nanomedicine Consumption (2017-2022)

    • 7.3 Europe Nanomedicine Consumption (2017-2022)

    • 7.4 China Nanomedicine Consumption (2017-2022)

    • 7.5 Japan Nanomedicine Consumption (2017-2022)

    • 7.6 India Nanomedicine Consumption (2017-2022)

    • 7.7 South Korea Nanomedicine Consumption (2017-2022)

    8 Region and Country-wise Nanomedicine Market Analysis and Outlook to 2028

    • 8.1 Global Nanomedicine Consumption Forecast (2022-2028)

    • 8.2 United States Nanomedicine Consumption Forecast (2022-2028)

    • 8.3 Europe Nanomedicine Consumption Forecast (2022-2028)

    • 8.4 China Nanomedicine Consumption Forecast (2022-2028)

    • 8.5 Japan Nanomedicine Consumption Forecast (2022-2028)

    • 8.6 India Nanomedicine Consumption Forecast (2022-2028)

    • 8.7 South Korea Nanomedicine Consumption Forecast (2022-2028)

    9 Global Nanomedicine Market Outlook by Types and Applications to 2022

    • 9.1 Global Nanomedicine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Regenerative Medicine Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global In-vitro & In-vivo Diagnostics Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Drug Delivery Consumption and Growth Rate (2017-2022)

    • 9.2 Global Nanomedicine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinical Cardiology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Urology Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Genetics Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Orthopedics Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Ophthalmology Consumption and Growth Rate (2017-2022)

    10 Global Nanomedicine Market Outlook by Types and Applications to 2028

    • 10.1 Global Nanomedicine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Regenerative Medicine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global In-vitro & In-vivo Diagnostics Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Nanomedicine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinical Cardiology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Urology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Genetics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Orthopedics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Ophthalmology Consumption Forecast and Growth Rate (2022-2028)

    11 Global Nanomedicine Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Nanomedicine Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Nanomedicine Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Nanomedicine Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Nanomedicine Market Competitive Analysis

    • 14.1 Nanosphere Inc

      • 14.1.1 Nanosphere Inc Company Details

      • 14.1.2 Nanosphere Inc Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Nanosphere Inc Nanomedicine Product and Service

    • 14.2 Pfizer Inc

      • 14.2.1 Pfizer Inc Company Details

      • 14.2.2 Pfizer Inc Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pfizer Inc Nanomedicine Product and Service

    • 14.3 Smith & Nephew PLC

      • 14.3.1 Smith & Nephew PLC Company Details

      • 14.3.2 Smith & Nephew PLC Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Smith & Nephew PLC Nanomedicine Product and Service

    • 14.4 Sigma-Tau Pharmaceuticals Inc

      • 14.4.1 Sigma-Tau Pharmaceuticals Inc Company Details

      • 14.4.2 Sigma-Tau Pharmaceuticals Inc Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sigma-Tau Pharmaceuticals Inc Nanomedicine Product and Service

    • 14.5 Mallinckrodt plc

      • 14.5.1 Mallinckrodt plc Company Details

      • 14.5.2 Mallinckrodt plc Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Mallinckrodt plc Nanomedicine Product and Service

    • 14.6 Merck & Co Inc

      • 14.6.1 Merck & Co Inc Company Details

      • 14.6.2 Merck & Co Inc Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Merck & Co Inc Nanomedicine Product and Service

    • 14.7 GE Healthcare

      • 14.7.1 GE Healthcare Company Details

      • 14.7.2 GE Healthcare Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 GE Healthcare Nanomedicine Product and Service

    • 14.8 Johnson & Johnson

      • 14.8.1 Johnson & Johnson Company Details

      • 14.8.2 Johnson & Johnson Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Johnson & Johnson Nanomedicine Product and Service

    • 14.9 Stryker Corp

      • 14.9.1 Stryker Corp Company Details

      • 14.9.2 Stryker Corp Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Stryker Corp Nanomedicine Product and Service

    • 14.10 Teva Pharmaceutical Industries Ltd

      • 14.10.1 Teva Pharmaceutical Industries Ltd Company Details

      • 14.10.2 Teva Pharmaceutical Industries Ltd Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Teva Pharmaceutical Industries Ltd Nanomedicine Product and Service

    • 14.11 UCB (Union chimique belge) SA

      • 14.11.1 UCB (Union chimique belge) SA Company Details

      • 14.11.2 UCB (Union chimique belge) SA Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 UCB (Union chimique belge) SA Nanomedicine Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Nanomedicine

    • Figure Nanomedicine Picture

    • Table Global Nanomedicine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nanomedicine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nanomedicine Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Nanomedicine Consumption by Country (2017-2022)

    • Figure United States Nanomedicine Consumption and Growth Rate (2017-2022)

    • Table Europe Nanomedicine Consumption and Growth Rate (2017-2022)

    • Figure China Nanomedicine Consumption and Growth Rate (2017-2022)

    • Figure Japan Nanomedicine Consumption and Growth Rate (2017-2022)

    • Figure India Nanomedicine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Nanomedicine Consumption and Growth Rate (2017-2022)

    • Figure Global Nanomedicine Consumption Forecast by Country (2022-2028)

    • Figure United States Nanomedicine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Nanomedicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Nanomedicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Nanomedicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Nanomedicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Nanomedicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Regenerative Medicine Consumption and Growth Rate (2017-2022)

    • Figure Global In-vitro & In-vivo Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Delivery Consumption and Growth Rate (2017-2022)

    • Figure Global Clinical Cardiology Consumption and Growth Rate (2017-2022)

    • Figure Global Urology Consumption and Growth Rate (2017-2022)

    • Figure Global Genetics Consumption and Growth Rate (2017-2022)

    • Figure Global Orthopedics Consumption and Growth Rate (2017-2022)

    • Figure Global Ophthalmology Consumption and Growth Rate (2017-2022)

    • Figure Global Regenerative Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global In-vitro & In-vivo Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Delivery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinical Cardiology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Urology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Genetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Orthopedics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ophthalmology Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Nanomedicine Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Nanomedicine Export by Region (Top 5 Countries) (2017-2028)

    • Table Nanosphere Inc (Foundation Year, Company Profile and etc.)

    • Table Nanosphere Inc Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nanosphere Inc Nanomedicine Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Nanomedicine Product and Service

    • Table Smith & Nephew PLC (Foundation Year, Company Profile and etc.)

    • Table Smith & Nephew PLC Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Smith & Nephew PLC Nanomedicine Product and Service

    • Table Sigma-Tau Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Sigma-Tau Pharmaceuticals Inc Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sigma-Tau Pharmaceuticals Inc Nanomedicine Product and Service

    • Table Mallinckrodt plc (Foundation Year, Company Profile and etc.)

    • Table Mallinckrodt plc Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mallinckrodt plc Nanomedicine Product and Service

    • Table Merck & Co Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co Inc Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Inc Nanomedicine Product and Service

    • Table GE Healthcare (Foundation Year, Company Profile and etc.)

    • Table GE Healthcare Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare Nanomedicine Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Nanomedicine Product and Service

    • Table Stryker Corp (Foundation Year, Company Profile and etc.)

    • Table Stryker Corp Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stryker Corp Nanomedicine Product and Service

    • Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Ltd Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd Nanomedicine Product and Service

    • Table UCB (Union chimique belge) SA (Foundation Year, Company Profile and etc.)

    • Table UCB (Union chimique belge) SA Nanomedicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table UCB (Union chimique belge) SA Nanomedicine Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US